Concourse Financial Group Securities, Inc. Ice Cure Medical Ltd. Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share
Q3 2024 Oct 10, 2024	BUY	$0.58 - $0.83 $0 - $0
Q2 2024 Jul 23, 2024	BUY	$0.74 - $1.35 $0 - $0
Q1 2024 Apr 30, 2024	BUY	$1.16 - $1.48 $0 - $0
Q4 2023 Feb 07, 2024	BUY	$0.72 - $1.36 $0 - $0
Q3 2023 Oct 30, 2023	BUY	$0.54 - $1.33 $0 - $0
Q3 2023 Oct 25, 2023	BUY	$0.54 - $1.33 $0 - $0
Q2 2023 Aug 10, 2023	BUY	$1.06 - $1.4 $0 - $0
Q1 2023 May 15, 2023	BUY	$1.05 - $1.49 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$0.94 - $2.6 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$1.12 - $2.03 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$1.71 - $2.47 $0 - $0
Q1 2022 May 09, 2022	BUY	$2.01 - $3.31 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$2.73 - $8.7 $0 - $0
Q3 2021 Nov 09, 2021	BUY	$8.61 - $11.33 $0 - $0

Others Institutions Holding ICCM

# of Institutions

Shares Held

195K

Call Options Held

Put Options Held

View Full List

About IceCure Medical Ltd.

Ticker ICCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 36,835,600
Market Cap $22.1M
Description
IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.

More about ICCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account